Paul Hopper

Paul Hopper

Vermogen: 594 394 $ op 30-09-2026

70 jaar
Health Technology
Commercial Services
Finance

Profiel

Mr. Paul A. Hopper is an Executive Chairman at Radiopharm Theranostics Ltd., an Executive Chairman at Imugene Ltd., a Managing Director at Cappello Group, Inc., a Chairman at Vaxinia Pty Ltd., a MD, Head-Life Sciences & Biotechnology Group at Cappello Global LLC, a Member at Pacific Council on International Policy and a President & Director at Radiopharm Theranostics (USA), Inc. He is on the Board of Directors at Biolife Science Ltd. and Radiopharm Theranostics (USA), Inc. Mr. Hopper was previously employed as an Independent Director by Scopus Biopharma, Inc., an Executive Chairman by Chimeric Therapeutics Ltd. (Australia), an Executive Chairman by Arovella Therapeutics Ltd., a Non-Executive Director by Respiri Ltd., a Non-Executive Chairman by Viralytics Pty Ltd., an Independent Director by EyePoint Pharmaceuticals, Inc., an Executive Chairman by Cell Aquaculture Ltd., an Independent Non-Executive Director by Somnomed Ltd., an Executive Chairman by Bone Medical Ltd., a Chief Operating Officer & Director by Acuvax Ltd., a Managing Director by Australian Cancer Technology Ltd., a Non-Executive Director by Prescient Therapeutics Ltd., a Managing Director by Alpha Healthcare Ltd., a Chairman-California Chapter by American Australian Association, an Executive Chairman by Bioscience Oncology Pty Ltd., a Founder by Glioblast Pty Ltd., a President by Innovate Oncology, Inc., a Founder by Pathway Oncology Pty Ltd., a Lead Director by Polynoma LLC, and a Managing Director by The Merchants Bank of New York.
He also served on the board at Fibrocell Science, Inc., Advanced Biotherapy, Inc., C19 Therapeutics Pty Ltd. and Medaire Ltd. He received his undergraduate degree from The University of New South Wales.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
24-07-2025 12.614.263 ( 2,3% ) 368 589 $ 30-09-2026
30-06-2026 54.150.000 ( 1,15% ) 225 806 $ 30-09-2026

Actieve functies van Paul Hopper

BedrijvenFunctieBegin
IMUGENE LIMITED Oprichter 31-10-2012
RADIOPHARM THERANOSTICS LIMITED Oprichter 01-01-2021
Voorzitter -
Directeur/Bestuurslid -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 01-11-2005
President -

Eerdere bekende functies van Paul Hopper

BedrijvenFunctieEinde
CHIMERIC THERAPEUTICS LIMITED Oprichter 25-11-2025
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Paul Hopper in detail bekijken

Opleiding van Paul Hopper

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

67

Eerstegraads connecties

33

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit33

Commercial Services

Finance

Finance

Health Technology

Finance

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Commercial Services

Finance

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

C19 Therapeutics Pty Ltd.

Bioscience Oncology Pty Ltd.

Health Services

Health Technology

  1. Beurs
  2. Insiders
  3. Paul Hopper